SARS-CoV2 infection: functional and morphological cardiopulmonary changes in elite handball players.
Adult
Asymptomatic Infections
Athletes
/ statistics & numerical data
Athletic Performance
/ physiology
COVID-19
/ diagnosis
COVID-19 Nucleic Acid Testing
/ statistics & numerical data
Echocardiography
/ statistics & numerical data
Exercise Test
/ statistics & numerical data
Germany
Heart
/ diagnostic imaging
Humans
Lung
/ diagnostic imaging
Magnetic Resonance Imaging
Male
RNA, Viral
/ isolation & purification
Retrospective Studies
SARS-CoV-2
/ isolation & purification
Spirometry
/ statistics & numerical data
Young Adult
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
07 09 2021
07 09 2021
Historique:
received:
06
05
2021
accepted:
12
08
2021
entrez:
8
9
2021
pubmed:
9
9
2021
medline:
15
9
2021
Statut:
epublish
Résumé
There is increasing evidence of cardiac involvement post-SARS-CoV-2 infections in symptomatic as well as in oligo- and asymptomatic athletes. This study aimed to characterize the possible early effects of SARS-CoV-2 infections on myocardial morphology and cardiopulmonary function in athletes. Eight male elite handball players (27 ± 3.5 y) with past SARS-CoV-2 infection were compared with four uninfected teammates (22 ± 2.6 y). Infected athletes were examined 19 ± 7 days after the first positive PCR test. Echocardiographic assessment of the global longitudinal strain under resting conditions was not significantly changed (- 17.7% vs. - 18.1%). However, magnetic resonance imaging showed minor signs of acute inflammation/oedema in all infected athletes (T2-mapping: + 4.1 ms, p = 0.034) without reaching the Lake-Louis criteria. Spiroergometric analysis showed a significant reduction in VO2max (- 292 ml/min, - 7.0%), oxygen pulse (- 2.4 ml/beat, - 10.4%), and respiratory minute volume (VE) (- 18.9 l/min, - 13.8%) in athletes with a history of SARS-CoV2 infection (p < 0.05, respectively). The parameters were unchanged in the uninfected teammates. SARS-CoV2 infection caused impairment of cardiopulmonary performance during physical effort in elite athletes. It seems reasonable to screen athletes after SARS-CoV2 infection with spiroergometry to identify performance limitations and to guide the return to competition.
Identifiants
pubmed: 34493765
doi: 10.1038/s41598-021-97120-x
pii: 10.1038/s41598-021-97120-x
pmc: PMC8423785
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17798Informations de copyright
© 2021. The Author(s).
Références
Immunol Cell Biol. 2000 Oct;78(5):510-22
pubmed: 11050534
Acta Physiol Scand. 1992 Jan;144(1):23-9
pubmed: 1595350
Eur Heart J. 2020 Nov 14;41(43):4191-4199
pubmed: 32845299
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Neth Heart J. 2020 Jul;28(7-8):391-395
pubmed: 32662058
Int J Cardiovasc Imaging. 2020 Aug;36(8):1407-1416
pubmed: 32367188
J Sports Med Phys Fitness. 2016 Dec;56(12):1583-1591
pubmed: 26986993
Br J Sports Med. 2020 Nov 12;:
pubmed: 33184114
Medicina (Kaunas). 2021 Mar 17;57(3):
pubmed: 33802881
Eur Radiol. 2021 Feb;31(2):1090-1099
pubmed: 32860146
Front Physiol. 2020 Oct 15;11:588784
pubmed: 33178050
J Cardiovasc Echogr. 2020 Oct-Dec;30(4):206-210
pubmed: 33828942
Clin Res Cardiol. 2020 Dec;109(12):1549-1566
pubmed: 32803387
JACC Cardiovasc Imaging. 2020 Dec;13(12):2635-2652
pubmed: 33303102
PLoS Negl Trop Dis. 2011 Jul;5(7):e1239
pubmed: 21811643
Int J Cardiovasc Imaging. 2020 Oct;36(10):1855-1885
pubmed: 32462448
Clin Sports Med. 2011 Jul;30(3):525-36
pubmed: 21658546
Int J Cardiovasc Imaging. 2021 Aug;37(8):2369-2386
pubmed: 33738612
JAMA Cardiol. 2021 Jan 1;6(1):116-118
pubmed: 32915194
Cureus. 2020 May 8;12(5):e8021
pubmed: 32528760
J Sports Med Phys Fitness. 2021 Jul;61(7):977-982
pubmed: 33269880
Herz. 2020 May;45(3):230-232
pubmed: 32140732
Int J Cardiovasc Imaging. 2016 Jun;32(6):975-81
pubmed: 26920720
Br J Sports Med. 2020 Oct;54(19):1157-1161
pubmed: 32878870
PLoS One. 2020 Jul 23;15(7):e0235791
pubmed: 32702711
J Cardiovasc Pharmacol Ther. 2021 Jan;26(1):12-24
pubmed: 32924567
JAMA Cardiol. 2021 May 27;:
pubmed: 34042947
Int J Cardiol. 2017 Jun 15;237:67-70
pubmed: 28318658
Can J Cardiol. 2021 Aug;37(8):1165-1174
pubmed: 33248208